forty-six children treated by the six-drug a-cop+ regimen ( adriamycin [ doxorubicin ; adria laboratories , columbus , oh ] , vincristine , prednisone , cyclophosphamide , methotrexate , and hydrocortisone ) were compared in a prospective randomized trial with 30 patients receiving the modified ten-drug lsa2-l2 ( cyclosphosphamide , vincristine , methotrexate , daunomycin [ daunorubicin cerubidine ; wyeth laboratories , philadelphia ] , prednisone , cytarabine , thioguanine , asparaginase , hydroxyurea , and carmustine ) regimen .
C0013089
doxorubicin
C0011015
daunorubicin